Glucagon-like peptide-1 analogue-eluting beads - CellMed

Drug Profile

Glucagon-like peptide-1 analogue-eluting beads - CellMed

Alternative Names: CellBead Cardio; CellBead Neuro; CellBead-GLP-1; CM1-eluting bead; GLP-1 CellBead; GLP-1-eluting bead

Latest Information Update: 08 Apr 2014

Price : $50

At a glance

  • Originator CellMed
  • Class Glucagon-like peptides
  • Mechanism of Action Glucagon like peptide 1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Cardiovascular disorders; Stroke

Most Recent Events

  • 08 Apr 2014 Discontinued - Phase-I/II for Stroke in Germany (Intracerebral)
  • 08 Apr 2014 Discontinued - Phase-I for Cardiovascular disorders in United Kingdom (Intra-arterial)
  • 01 Jun 2011 Phase-I clinical trials in Cardiovascular disorders in United Kingdom (Intra-arterial)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top